Skip to main content

Table 3 Subgroup analysis of OS by different factors

From: Elective nodal irradiation versus involved-field irradiation for stage II–IV cervical esophageal squamous cell carcinoma patients undergoing definitive concurrent chemoradiotherapy: a retrospective propensity study with 8-year survival outcomes

Characteristics

1-year OS rate (%)

3-year OS rate (%)

5-year OS rate (%)

8-year OS rate (%)

P

ENI

IFI

ENI

IFI

ENI

IFI

ENI

IFI

Sex

         

 Male

76.9

92.0

38.1

46.2

32.6

26.9

27.2

10.8

0.858

 Female

91.3

87.5

60.6

58.3

45.4

47.7

34.1

41.8

0.784

Age at diagnosis (year)

         

 ≤65

85.7

87.5

48.3

53.1

38.6

42.1

30.1

29.8

0.861

 > 65

78.6

94.1

50.0

50.3

40.0

25.2

40.0

16.8

0.950

ECOG PS

         

 0

86.4

88.1

49.8

54.8

39.5

39.1

31.9

27.2

0.981

 1–2

60.0

100.0

42.9

0.979

cT stage

         

 T3

85.4

87.8

48.0

55.8

39.0

38.1

29.3

25.4

0.892

 T4

75.0

100.0

50.0

33.3

37.5

33.3

33.3

0.818

cN stage

         

 N0

91.7

100.0

48.6

54.5

38.9

24.2

38.9

24.2

0.601

  N+

81.1

86.8

48.5

51.9

38.8

41.9

27.6

26.9

0.722

8th AJCC stage

         

 II–III

85.4

87.8

48.0

55.8

39.0

38.1

29.3

25.4

0.892

 IV

75.0

100.0

50.0

33.3

37.5

33.3

33.3

0.818

Radiation dose (Gy)

         

 ≥ 50 Gy, ≤ 59.4 Gy

80.0

86.7

58.3

35.6

36.5

23.7

23.7

0.551

 > 59.4 Gy, ≤ 66 Gy

85.3

91.2

43.7

58.8

37.5

42.9

33.7

28.8

0.637